MannKind | MNKD - Acción





Acción Cambio Fecha
Adma Biologics USD 239.31M 17.22M 2026-06
BioCryst Pharmaceuticals USD 6.06M 71K 2026-06
Eli Lilly USD 16.79B 2.26B 2026-06
Halozyme Therapeutics USD 137.14M 18.33M 2026-06
Insmed USD 142.38M 9.48M 2026-06
Karyopharm Therapeutics USD 4.04M 72K 2025-12
MacroGenics USD 9.5M 1.59M 2026-03
MannKind USD 44.42M 4.75M 2026-06
Merck USD 6.21B 272M 2026-06
Novavax USD 10.01M 1.45M 2026-06
Novo Nordisk DKK 51.35B 8.5B 2026-03
Pfizer USD 9.94B 722M 2026-06
Sanofi EUR 24.12B 620M 2026-06